Actively Recruiting
Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
Led by Charles University, Czech Republic · Updated on 2024-06-18
80
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on bronchial asthma in children and adolescents aged 3 to 18 years, particularly examining both typical symptoms like cough, chest tightness, shortness of breath, and wheezing, and less common symptoms such as chronic productive cough, inspiratory dyspnoea, or recurrent pneumonia. It aims to understand the prevalence of these typical and atypical asthma symptoms and evaluate the sensitivity of the official asthma symptom questionnaire ISAAC in identifying asthma in children presenting with varying symptoms. The study is observational and involves children presenting for their first evaluation in a pulmonary outpatient clinic with respiratory symptoms such as cough, shortness of breath, chest tightness, wheezing, recurrent lung infections, or abnormal lung sounds. The investigators will document asthma symptoms using the ISAAC questionnaire and clinical assessment. Initial suspicion of asthma diagnosis will lead to therapy initiation, followed by a scheduled follow-up within three months to confirm the diagnosis. Participants will undergo an initial checkup with asthma symptom documentation and complete the ISAAC questionnaire. Investigators will monitor the prevalence of typical and atypical asthma symptoms over time and confirm asthma diagnosis through follow-up assessments. The study includes documentation of respiratory symptoms and clinical findings with the aim of improving understanding of asthma presentation in children. The total study duration extends to June 2026.
CONDITIONS
Brief Title
Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child aged 3 to 18 years
- First evaluation in pulmonary outpatient clinic for respiratory symptoms such as cough, shortness of breath, chest tightness, wheezing, recurrent lower respiratory tract and lung infections, dyspnoea, or abnormal lung sounds
You will not qualify if you...
- Presence of other documented chronic respiratory, cardiovascular, neurological, genetic, infectious, or metabolic diseases
- Significant immaturity or other diseases that may cause respiratory symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 months
Participants undergo initial checkup with asthma symptom documentation and complete the ISAAC questionnaire to assess typical and atypical asthma symptoms.
1 initial visit and 1 follow-up visit within 3 months
Duration - Ongoing as determined by healthcare providers
Participants with suspected asthma receive observation to confirm diagnosis and evaluate symptom progression over time.
Additional visits depending on clinical needs
Trial Site Locations
Total: 1 location
1
First faculty of Medicine, Charles university.
Prague, Czechia, 128 00
Actively Recruiting
Research Team
J
Jana Tukova
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here